NO904184L - Anvendelse av alkylfosforsyreforbindelser for bekjempelseav psoriasis-sykdommer. - Google Patents

Anvendelse av alkylfosforsyreforbindelser for bekjempelseav psoriasis-sykdommer.

Info

Publication number
NO904184L
NO904184L NO90904184A NO904184A NO904184L NO 904184 L NO904184 L NO 904184L NO 90904184 A NO90904184 A NO 90904184A NO 904184 A NO904184 A NO 904184A NO 904184 L NO904184 L NO 904184L
Authority
NO
Norway
Prior art keywords
fighting
application
acid compounds
alkylphosphoric acid
psoriasis diseases
Prior art date
Application number
NO90904184A
Other languages
English (en)
Norwegian (no)
Other versions
NO904184D0 (no
Inventor
Hansjoerg Eibl
Clemens Unger
Juergen Engel
Original Assignee
Asta Pharma Ag
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6390272&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO904184(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asta Pharma Ag, Max Planck Gesellschaft filed Critical Asta Pharma Ag
Publication of NO904184D0 publication Critical patent/NO904184D0/no
Publication of NO904184L publication Critical patent/NO904184L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO90904184A 1989-09-27 1990-09-26 Anvendelse av alkylfosforsyreforbindelser for bekjempelseav psoriasis-sykdommer. NO904184L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3932183 1989-09-27

Publications (2)

Publication Number Publication Date
NO904184D0 NO904184D0 (no) 1990-09-26
NO904184L true NO904184L (no) 1991-04-02

Family

ID=6390272

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90904184A NO904184L (no) 1989-09-27 1990-09-26 Anvendelse av alkylfosforsyreforbindelser for bekjempelseav psoriasis-sykdommer.

Country Status (17)

Country Link
EP (2) EP0916343A1 (fi)
JP (1) JP3176615B2 (fi)
CA (1) CA2026278C (fi)
DD (1) DD298052A5 (fi)
DE (1) DE4029747C2 (fi)
EG (1) EG19338A (fi)
FI (1) FI904726A0 (fi)
HU (1) HU209589B (fi)
IE (1) IE903464A1 (fi)
LT (1) LT3804B (fi)
LV (1) LV10391B (fi)
MC (1) MC2150A1 (fi)
NO (1) NO904184L (fi)
PT (1) PT95422B (fi)
RU (1) RU1837877C (fi)
UA (1) UA19335A (fi)
ZA (1) ZA907702B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958906A (en) * 1992-10-01 1999-09-28 Asta-Medica Aktiengesellschaft Phospholipid derivatives containing higher elements of the fifth main group
DE4233044A1 (de) * 1992-10-01 1994-04-07 Asta Medica Ag Phospholipidderivate, die höhere Elemente der V. Hauptgruppe enthalten
DE4235911A1 (de) * 1992-10-23 1994-04-28 Asta Medica Ag Stabilisierte Hexadecylphosphocholinlösungen in Glycerinalkylethern
NZ505648A (en) 1998-01-22 2002-10-25 Zentaris Ag Hexadecylphosphocholine (HPC) and a flow controlling agent and/or a lubricant and a filler in a daily dosage of 10-250 mg
DE102006004821B4 (de) * 2006-01-30 2020-12-10 Cuma Kilic Sammelbehältnis für Abfall und Bauschutt
BR112012000476A2 (pt) 2009-07-09 2016-11-22 Expergen Drug Dev Gmbh forma farmacêutica líquida de alquilfosfocolina e método de preparação da mesma.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761404A (en) * 1985-07-01 1988-08-02 Merck & Co., Inc. Phospholipid analogs useful as PAF synthesis inhibitors
CA1338627C (en) * 1985-12-04 1996-10-01 Hansjorg Eibl Pharmaceuticals based on phosphoric acid esters for use in tumor therapy, and process for their preparation
DE3829899C2 (de) * 1988-09-02 1994-12-15 Reutter Werner Glyceringlycophosphatide und diese enthaltende pharmazeutische Mittel zur Bekämpfung von Hauterkrankungen

Also Published As

Publication number Publication date
DD298052A5 (de) 1992-02-06
DE4029747C2 (de) 2003-10-02
FI904726A0 (fi) 1990-09-26
MC2150A1 (fr) 1992-03-10
IE903464A1 (en) 1991-04-10
DE4029747A1 (de) 1991-04-11
HU209589B (en) 1994-08-29
HUT55992A (en) 1991-07-29
EP0419998A2 (de) 1991-04-03
NO904184D0 (no) 1990-09-26
RU1837877C (ru) 1993-08-30
CA2026278A1 (en) 1991-03-28
ZA907702B (en) 1991-07-31
LTIP1488A (en) 1995-06-26
LV10391A (lv) 1995-02-20
EG19338A (en) 1994-12-30
EP0419998A3 (en) 1991-10-23
LV10391B (en) 1995-10-20
HU906233D0 (en) 1991-03-28
PT95422A (pt) 1991-05-22
PT95422B (pt) 1997-07-31
LT3804B (en) 1996-03-25
EP0916343A1 (de) 1999-05-19
UA19335A (uk) 1997-12-25
CA2026278C (en) 1996-04-30
JP3176615B2 (ja) 2001-06-18
JPH03130228A (ja) 1991-06-04

Similar Documents

Publication Publication Date Title
NO173238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-beta-(karboksyalkenoylamino)-3-cefem-4-karboksylsyre-forbindelser
NO862734L (no) Fremgangsmaate for fremstilling av hyaluronsyreestere.
NO882004L (no) Syntese av dpdp-(mono)eddiksyre analog.
NO814424L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme 5,5`-azobis-salisylsyreforbindelser.
FI953899A0 (fi) Substituoituja atsolonijohdannaisia Helicobacterin aiheuttamien sairauksien hoitamiseksi
NO885601D0 (no) Eventuelt kvataererte fettsyreestre av oxalkylerte alkyl-alkylendiaminer.
NO904184D0 (no) Anvendelse av alkylfosforsyreforbindelser for bekjempelseav psoriasis-sykdommer.
IS2721A7 (is) Aðferð til framleiðslu lyfjasamsetninga til húðlækninga
PT88545A (pt) Process for the manufacture of benzimidazoline-2-oxo-1-carboxylic acid derivative compounds
IT1173725B (it) Composizione terapeutica a base di acido 5-idrossi-decanoico o suoi de rivati,per il trattamento di malattie cardiovascolari
IT1210935B (it) Composizione farmaceutica per il trattamento di malattie cardiovascolari.
IT1202916B (it) Composti derivati dell'acido cicloesilcarbossilico e loro procedimento di preparazione
IT8848398A0 (it) Utilizzatore farmaceutica di acido 3 -indolpiruvico come agente inibitore di patologie degenerative
NO900432L (no) Fremgangsmaate for fremstilling av nye aryl- eller heteroaryl-1-alkyl-pyrrol-2-carboxylsyreforbindelser.
NO893326D0 (no) Fremgangsmaate for noeytralisering av svovelsyre inneholdende sinkioner.
FI945353A0 (fi) Entsymaattinen menetelmä (S)-6-metoksyyli-alfa-metyyli-2-naftaleenietikkahapon valmistamiseksi
NO164599C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 7-d-mandelamido-3-(1-sulfometyl-tetrazol-5-yl)-tiometyl-3-cefem-4-karboksylsyre-mononatriumsalt.
NO166322C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroapovincaminsyrederivater.
DE3888505D1 (de) Herstellung von Zimtsäureestern.
NO901687D0 (no) Fremgangsmaate for fremstilling av thiazetokinolin-3-carboxylsyrederivater.
IT8419940A0 (it) Nuovi medicinali per il trattamento di malattie cardiache.
IT8423360A0 (it) Procedimento di preparazione dell'acido 3-idrossi-3-metil-glutarico.
DE69004974D1 (de) Herstellung von 2-Chlorterephthalsäurechlorid.
DK639088D0 (da) Laegemiddel til behandling af iskaemiske hjertesygdomme
NO874724D0 (no) Fremgangsmaate for fremstilling av hydrerte 1-fenoksy-alkylpyridin-3-karboksylsyreforbindelser.